The CD70 Antibody Cusatuzumab Shows Promise in Acute Myeloid Leukemia

Article navigation

Research Watch| September 01 2020

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2020

American Association for Cancer Research.

Cancer Discov (2020) 10 (9): 1251.

Abstract

Cusatuzumab synergized with a hypomethylating agent in older patients with acute myeloid leukemia.

2020

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.